scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0168-8278(99)80061-0 |
P698 | PubMed publication ID | 10068095 |
P50 | author | Bettina Hansen | Q40007319 |
P2093 | author name string | J T Brouwer | |
S W Schalm | |||
H G Niesters | |||
P2860 | cites work | Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach | Q29614698 |
Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers. | Q36865888 | ||
Factors predictive of a beneficial response to therapy of hepatitis C. | Q40882250 | ||
Measuring hepatitis C viremia in clinical samples: Can we trust the assays? | Q41523834 | ||
Therapy of hepatitis C: overview | Q41598802 | ||
A French consensus conference on hepatitis C: screening and treatment | Q41651187 | ||
International collaborative study on the second EUROHEP HCV-RNA reference panel | Q42978378 | ||
Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison | Q42985824 | ||
Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group | Q42986315 | ||
Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa | Q42987319 | ||
Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients | Q42989126 | ||
Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy | Q42989131 | ||
A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group | Q43039883 | ||
Treatment of chronic hepatitis C with high-dose interferon alpha-2b. A multicenter study | Q43048305 | ||
Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group | Q70955349 | ||
Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration | Q71650797 | ||
National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C | Q73717356 | ||
P433 | issue | 2 | |
P921 | main subject | ribavirin | Q421862 |
chronic hepatitis C | Q55779873 | ||
P304 | page(s) | 192-198 | |
P577 | publication date | 1999-02-01 | |
P1433 | published in | Journal of Hepatology | Q15724402 |
P1476 | title | Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT. | |
P478 | volume | 30 |